Airway inflammation in a novel mouse model of asthma-COPD overlap induced by co-exposure to papain and tobacco smoke
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved..
Asthma and chronic obstructive pulmonary disease (COPD) are respiratory diseases associated with airway inflammation, which is the main pathogenesis. Although their causes and characteristics differ, in some cases, asthma and COPD may coexist in the same patient in a condition called asthma-COPD overlap (ACO). The prognosis of ACO is more unfavourable than those of asthma or COPD alone, without any treatment strategies demonstrating efficacy. Owing to its intricate spectrum of features, the detailed pathogenesis of how ACO exacerbates respiratory features remains unclear. In this study, we exposed papain-induced asthma model mice to tobacco smoke to establish an ACO mouse model, in which features of airway inflammation observed in both asthma and COPD were incorporated. This model exhibited distinctive mixed and corticosteroid-resistant airway inflammation and emphysematous changes that are characteristic of ACO. The novel mouse model established here is expected to significantly contribute to elucidating the mechanisms of the broad pathologies of ACO and identifying potential therapeutic targets.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:709 |
---|---|
Enthalten in: |
Biochemical and biophysical research communications - 709(2024) vom: 21. Apr., Seite 149831 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kimura, Genki [VerfasserIn] |
---|
Links: |
---|
Themen: |
Airway inflammation |
---|
Anmerkungen: |
Date Completed 15.04.2024 Date Revised 15.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.bbrc.2024.149831 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370420810 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370420810 | ||
003 | DE-627 | ||
005 | 20240415233611.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240331s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.bbrc.2024.149831 |2 doi | |
028 | 5 | 2 | |a pubmed24n1376.xml |
035 | |a (DE-627)NLM370420810 | ||
035 | |a (NLM)38552552 | ||
035 | |a (PII)S0006-291X(24)00367-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kimura, Genki |e verfasserin |4 aut | |
245 | 1 | 0 | |a Airway inflammation in a novel mouse model of asthma-COPD overlap induced by co-exposure to papain and tobacco smoke |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.04.2024 | ||
500 | |a Date Revised 15.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved. | ||
520 | |a Asthma and chronic obstructive pulmonary disease (COPD) are respiratory diseases associated with airway inflammation, which is the main pathogenesis. Although their causes and characteristics differ, in some cases, asthma and COPD may coexist in the same patient in a condition called asthma-COPD overlap (ACO). The prognosis of ACO is more unfavourable than those of asthma or COPD alone, without any treatment strategies demonstrating efficacy. Owing to its intricate spectrum of features, the detailed pathogenesis of how ACO exacerbates respiratory features remains unclear. In this study, we exposed papain-induced asthma model mice to tobacco smoke to establish an ACO mouse model, in which features of airway inflammation observed in both asthma and COPD were incorporated. This model exhibited distinctive mixed and corticosteroid-resistant airway inflammation and emphysematous changes that are characteristic of ACO. The novel mouse model established here is expected to significantly contribute to elucidating the mechanisms of the broad pathologies of ACO and identifying potential therapeutic targets | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Airway inflammation | |
650 | 4 | |a Asthma | |
650 | 4 | |a Asthma and COPD overlap | |
650 | 4 | |a COPD | |
650 | 4 | |a Papain | |
650 | 4 | |a Tobacco smoke | |
650 | 7 | |a Papain |2 NLM | |
650 | 7 | |a EC 3.4.22.2 |2 NLM | |
650 | 7 | |a Tobacco Smoke Pollution |2 NLM | |
700 | 1 | |a Tagami, Ai |e verfasserin |4 aut | |
700 | 1 | |a Fukui, Rina |e verfasserin |4 aut | |
700 | 1 | |a Yaita, Masaki |e verfasserin |4 aut | |
700 | 1 | |a Miyasaka, Tomohiro |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Biochemical and biophysical research communications |d 1960 |g 709(2024) vom: 21. Apr., Seite 149831 |w (DE-627)NLM000000035 |x 1090-2104 |7 nnns |
773 | 1 | 8 | |g volume:709 |g year:2024 |g day:21 |g month:04 |g pages:149831 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bbrc.2024.149831 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 709 |j 2024 |b 21 |c 04 |h 149831 |